NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.
Also called NCT06403267
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 600 participants
- Sponsor
- Registry
-
NCT06403267
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT06403267. Randomized; no masking; primary purpose treatment. Start 2024-10-02 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- NoNO-42
- Lead sponsor
- NoNO Inc.
- Collaborator
- University of Calgary
Record details
- Record id
cardio:ct-nct06403267- Content hash
38001657fe4ed6c886735fe74119df5c90118a4b9bdc1b0ecb90fd43838c22e9